Search results
Mr. Gordon Binder is the Chairman of the Board of Directors of NEUVOGEN. He was Chief Executive Officer of Amgen, Inc. the world’s largest biotech company, from 1988 through 2000.
Alumni Achievement Awards 2000: Gordon M. Binder Initiatives focus on societal challenges that are too complex for any one discipline or industry to solve alone. ǁ
He is the Founder and Managing Director of Coastview Capital, a private investment firm. [1] [3] [5] He also serves as Chairman of SRU Biosystems. [6] He sits on the Boards of Directors of Acadia Pharmaceuticals , Cellular Genomics, PhRMA and the Biotechnology Industry Organization .
Gordon M. Binder is Board of Directors at American Enterprise Institute.
Coastview Capital was a venture capital firm that was located in Southern California and was focused solely on life science investments. Who is the founder of Coastview Capital? Gordon Binder is the founder of Coastview Capital.
3 mar 2002 · Almost a year after starting a local biomedical venture capital firm, retired Amgen Inc. Chairman Gordon Binder is close to raising his first fund, which is set at $100 million, sources say.
Gordon and Adele Binder. SOURCE OF WEALTH: Coastview Capital, Amgen. FUNDING AREAS: Education & Youth, Policy, Arts & Culture, Health & Human Services, Jewish Causes.
